Literature DB >> 14959831

Codon-optimized genes that enable increased heterologous expression in mammalian cells and elicit efficient immune responses in mice after vaccination of naked DNA.

Marcus Graf1, Ludwig Deml, Ralf Wagner.   

Abstract

Many of the problems related with mammalian gene expression, such as low translation efficiency and mRNA halflife, can be solved by means of a rational gene design, based on modern bioinformatics, followed by the de novo generation of a synthetic gene. Moreover, high expression rates and prolonged mRNA stability are not only crucial for heterologous mammalian expression, but, in particular, are important for the generation of effective DNA vaccines. In this chapter we show that an optimized synthetic gene encoding the HIV-1 Pr55gag outperforms wild-type gene driven expression by several orders of magnitude. RNA analysis revealed that this positive effect was mostly due to increased mRNA stability of the optimized transcripts. Moreover, mice vaccinated with the optimized gag gene elicited a much stronger immune response against Pr55gag than the control groups immunized with the respective wild-type gene.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14959831     DOI: 10.1385/1-59259-679-7:197

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  15 in total

1.  IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaques.

Authors:  Rashmi Jalah; Vainav Patel; Viraj Kulkarni; Margherita Rosati; Candido Alicea; Brunda Ganneru; Agneta von Gegerfelt; Wensheng Huang; Yongjun Guan; Kate E Broderick; Niranjan Y Sardesai; Celia LaBranche; David C Montefiori; George N Pavlakis; Barbara K Felber
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

2.  Toward more efficient protein expression: keep the message simple.

Authors:  Stephan Kalwy; James Rance; Robert Young
Journal:  Mol Biotechnol       Date:  2006-10       Impact factor: 2.695

3.  The impact of intragenic CpG content on gene expression.

Authors:  Asli Petra Bauer; Doris Leikam; Simone Krinner; Frank Notka; Christine Ludwig; Gernot Längst; Ralf Wagner
Journal:  Nucleic Acids Res       Date:  2010-03-04       Impact factor: 16.971

Review 4.  DNA vaccines for targeting bacterial infections.

Authors:  Mariana Ingolotti; Omkar Kawalekar; Devon J Shedlock; Karuppiah Muthumani; David B Weiner
Journal:  Expert Rev Vaccines       Date:  2010-07       Impact factor: 5.217

5.  Comparison of immune responses generated by optimized DNA vaccination against SIV antigens in mice and macaques.

Authors:  Viraj Kulkarni; Rashmi Jalah; Brunda Ganneru; Cristina Bergamaschi; Candido Alicea; Agneta von Gegerfelt; Vainav Patel; Gen-Mu Zhang; Bhabadeb Chowdhury; Kate E Broderick; Niranjan Y Sardesai; Antonio Valentin; Margherita Rosati; Barbara K Felber; George N Pavlakis
Journal:  Vaccine       Date:  2010-12-30       Impact factor: 3.641

6.  Impact of ETIF deletion on safety and immunogenicity of equine herpesvirus type 1-vectored vaccines.

Authors:  Helga Hofmann-Sieber; Jens Wild; Nicole Fiedler; Karsten Tischer; Jens von Einem; Nikolaus Osterrieder; Heike Hofmann; Josef Köstler; Ralf Wagner
Journal:  J Virol       Date:  2010-09-08       Impact factor: 5.103

7.  Optimized lentiviral vector to restore full-length dystrophin via a cell-mediated approach in a mouse model of Duchenne muscular dystrophy.

Authors:  Jinhong Meng; Marc Moore; John Counsell; Francesco Muntoni; Linda Popplewell; Jennifer Morgan
Journal:  Mol Ther Methods Clin Dev       Date:  2022-05-02       Impact factor: 5.849

8.  Multiparameter RNA and codon optimization: a standardized tool to assess and enhance autologous mammalian gene expression.

Authors:  Stephan Fath; Asli Petra Bauer; Michael Liss; Anne Spriestersbach; Barbara Maertens; Peter Hahn; Christine Ludwig; Frank Schäfer; Marcus Graf; Ralf Wagner
Journal:  PLoS One       Date:  2011-03-03       Impact factor: 3.240

9.  In silico analysis of chimeric espA, eae and tir fragments of Escherichia coli O157:H7 for oral immunogenic applications.

Authors:  Jafar Amani; S Latif Mousavi; Sima Rafati; Ali H Salmanian
Journal:  Theor Biol Med Model       Date:  2009-12-08       Impact factor: 2.432

10.  Improved efficacy of a gene optimised adenovirus-based vaccine for venezuelan equine encephalitis virus.

Authors:  Amanda J Williams; Lyn M O'Brien; Robert J Phillpotts; Stuart D Perkins
Journal:  Virol J       Date:  2009-07-31       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.